Livzon Pharmaceutical Group Inc. (SHE:000513)
China · Delayed Price · Currency is CNY 31.06
-0.12 (-0.38%)
May 20, 2026, 11:15 AM CST
SHE:000513 Market Cap
SHE:000513 has a market cap or net worth of 25.46 billion as of May 19, 2026. Its market cap has decreased by -8.14% in one year.
Market Cap
25.46B
Enterprise Value
19.53B
Revenue
11.71B
Ranking
n/a
PE Ratio
14.15
Stock Price
31.06
Market Cap Chart
Since July 14, 1997, SHE:000513's market cap has increased from 392.67M to 25.46B, an increase of 6,383.50%. That is a compound annual growth rate of 15.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2026 | 25.46B | -8.92% |
| Dec 31, 2025 | 27.95B | -8.97% |
| Dec 31, 2024 | 30.70B | 8.53% |
| Dec 29, 2023 | 28.29B | 3.04% |
| Dec 30, 2022 | 27.46B | -15.01% |
| Dec 31, 2021 | 32.31B | -2.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Humanwell Healthcare (Group) | 29.33B |
| Tianjin Pharmaceutical Da Ren Tang Group Corporation | 29.09B |
| Shijiazhuang Yiling Pharmaceutical | 27.32B |
| Hubei Jumpcan Pharmaceutical | 25.51B |
| Zhejiang Huahai Pharmaceutical | 24.44B |
| Dizal (Jiangsu) Pharmaceutical | 23.64B |
| Walvax Biotechnology | 22.69B |
| Kangmei Pharmaceutical | 21.99B |